Moreover, we observed that fingolimod modulated inflammatory cytokines and affected the Akt/mTOR/NF‐κB axis in c‐EAN rats, which could be beneficial for CIDP patients. Here, AKT1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.